Tizona Therapeuticsincis A Biotechnology Company Based In South San Franciscocaliforniafounded In 2014The Company Specializes In Developing Innovative Immunotherapies Aimed At Treating Cancer And Autoimmune Diseases By Leveraging The Immune Systemtizona Was Established By Mpm Capital And Leading Scientists From Renowned Institutionsincluding Dana Farber Cancer Institute And Johns Hopkins The Company Focuses On Creating Therapies That Modulate Immunosuppressive Cells To Enhance The Body S Ability To Combat Cancer Or To Protect Healthy Tissues In Autoimmune Conditionstizona S Pipeline Features First In Class Immunotherapies Targeting The Mechanisms Responsible For Immune Suppression In Tumors And Self Reactivity In Autoimmunitynotable Candidates Include An Anti Ccr4 Monoclonal Antibody And Ttx 080Which Is Being Evaluated For Advanced Colorectal Cancer And Head And Neck Squamous Cell Carcinoma Led By Ceo Christine Oae Brientizona Therapeutics Has Raised Significant Funding To Support Its Research And Development Initiativesthe Company Is Committed To Improving Treatment Outcomes For Cancer Patients Through Collaboration And The Application Of Novel Scientific Insights
No conferences found for this company.
| Company Name | Tizona Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
